← Back
Data updated: Mar 29, 2026
FOUGERA PHARMS
DermatologyOphthalmologyInfectious Disease
Pharma
FOUGERA PHARMS is a pharmaceutical company focused on Dermatology, Ophthalmology, Infectious Disease.
1953
Since
50
Drugs
-
Trials
200
Approved (2yr)
Key Drugs
No active drugs
Top Drug Revenues Pro
Loading...
Revenue Over Time Pro
Loading...
Therapeutic Areas
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Dermatology 38%
3 drugs
Ophthalmology 25%
2 drugs
Infectious Disease 13%
1 drugs
Oncology 13%
1 drugs
Cardiovascular 13%
1 drugs
Pipeline Forecast
Loading...
Loading...
Upcoming Trial Milestones Pro
Loading...
Patent Cliff Pro
Loading...
Loading...
Loading...
Competitors by Therapeutic Area
Baxter specialty
Infectious Disease, Cardiovascular, Oncology, Dermatology, Ophthalmology
Bayer big-pharma
Oncology, Cardiovascular, Ophthalmology, Dermatology
B BRAUN specialty
Infectious Disease, Ophthalmology, Dermatology, Cardiovascular
Pfizer big-pharma
Oncology, Infectious Disease, Dermatology
COSETTE other
Cardiovascular, Dermatology, Infectious Disease, Oncology
Active (25)
ADAPALENE IMIQUIMOD TACROLIMUS CALCIPOTRIENE PREDNICARBATE ALCLOMETASONE DIPROPIONATE FLUTICASONE PROPIONATE MUPIROCIN CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE KETOCONAZOLE HYDROCORTISONE VALERATE DESOXIMETASONE CICLOPIROX ACYCLOVIR CLOTRIMAZOLE FLUOCINONIDE EMULSIFIED BASE OXISTAT CLINDAMYCIN PHOSPHATE BETAMETHASONE DIPROPIONATE NITROGLYCERIN TYZINE NYSTATIN FLUOCINONIDE ERYTHROMYCIN SULFACETAMIDE SODIUM
Discontinued (24)
METRONIDAZOLE LIDOCAINE MOMETASONE FUROATE TAZAROTENE CLOBETASOL PROPIONATE TRIAMCINOLONE ACETONIDE FLUOCINOLONE ACETONIDE TERCONAZOLE HYDROCORTISONE LIDOCAINE AND PRILOCAINE SOLARAZE BETAMETHASONE VALERATE GENTAMICIN SULFATE DESONIDE NYSTATIN AND TRIAMCINOLONE ACETONIDE CUTIVATE CLOBETASOL PROPIONATE (EMOLLIENT) TEMOVATE E ACLOVATE PAMINE FORTE PAMINE TEMOVATE C-SOLVE-2 CARMOL HC
Company Info
- First Approval
- 1953-04-09
- Latest
- 2026-02-24
- Applications
- 105
FDA Sponsor Names
FOUGERA PHARMSFOUGERA PHARMS INC